{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:47:59Z","timestamp":1793918879470,"version":"4.8.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Tumor human papillomavirus (HPV) status is an important prognostic factor in vulvar cancer as indicated in the latest WHO classification of female genital tract tumors. Immunohistochemical detection of p16 is well established as a surrogate biomarker for tumor HPV association, including squamous cell carcinomas of the vulva. HPV-independent vulvar carcinomas are heterogeneous with 2 subcategories according to the <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutation status. Therefore, the simultaneous use of p53 and p16 immunohistochemistry is recommended for accurate subclassification of vulvar squamous cell carcinomas. However, the role of molecular analytical tools, in particular RNA ISH and <jats:italic toggle=\"yes\">TP53<\/jats:italic> sequencing, is not so clear. This study aimed to investigate the performance of p53 and p16 immunohistochemistry for the diagnosis of vulvar carcinomas in comparison to <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutation analysis and HPV RNA ISH. We analyzed 48 vulvar carcinomas in a tissue microarray format. Sensitivity and specificity for both methods, p16 (100% and 96%) and p53 (95% and 90%) immunohistochemistry for detection of HPV association as well as for <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutations was high. Combining p16 and p53 immunohistochemistry we correctly classified all carcinomas in our series according to current WHO criteria. The sensitivity of HPV RNA ISH for the detection of HPV association was lower compared to p16 immunohistochemistry. Rare HPV-associated cases with <jats:italic toggle=\"yes\">TP53<\/jats:italic> mutation and HPV-independent tumors with p16 overexpression are discussed. In summary, the combined use of p16 and p53 immunohistochemistry for subclassification of vulvar carcinomas is justified in daily practice. Molecular tests should be restricted to rare cases with ambiguous clinicopathologic or immunohistochemical features.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001077","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T13:00:35Z","timestamp":1730379635000},"page":"308-313","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Role of Immunohistochemical Analysis of p16 and p53 in Vulvar Carcinoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Matthias","family":"Choschzick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladina","family":"Hoesli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Stergiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"R2-20250613","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1158\/1078-0432.CCR-17-1302","article-title":"Genomic characterization of vulvar (pre)cancers identifies distinct molecular subtypes with prognostic significance","volume":"23","author":"Nooij","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R3-20250613","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PGP.0000000000000263","article-title":"p16 immunostaining allows for accurate subclassification of vulvar squamous cell carcinoma into HPV-associated and HPV-independent cases","volume":"35","author":"Cheng","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20250613","first-page":"PO.19.00406","article-title":"Vulvar squamous cell carcinoma: comprehensive genomic profiling of HPV+ versus HPV-forms reveals distinct sets of potentially actionable molecular targets","volume":"4","author":"Williams","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"R5-20250613","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod Pathol"},{"key":"R6-20250613","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.31006","article-title":"Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: a study of 1,594 cases","volume":"141","author":"Rakislova","year":"2017","journal-title":"Int J Cancer"},{"key":"R7-20250613","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","article-title":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","volume":"159","author":"Kortekaas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R8-20250613","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.modpat.2023.100145","article-title":"Classification of vulvar squamous cell carcinoma and precursor lesions by p16 and p53 Immunohistochemistry: considerations, caveats, and an algorithmic approach","volume":"36","author":"Yang","year":"2023","journal-title":"Mod Pathol"},{"key":"R9-20250613","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.2701","article-title":"Evidence for APOBEC3B mutagenesis in multiple human cancers","volume":"45","author":"Burns","year":"2013","journal-title":"Nat Genet"},{"key":"R10-20250613","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/modpathol.3800736","article-title":"D2-40 and calretinin\u2014a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation","volume":"20","author":"Hinterberger","year":"2007","journal-title":"Mod Pathol"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"154877","DOI":"10.1016\/j.prp.2023.154877","article-title":"NOTCH1 and PIK3CA mutation are related to HPV-associated vulvar squamous cell carcinoma","volume":"251","author":"Choschzick","year":"2023","journal-title":"Pathol Res Pract"},{"key":"R12-20250613","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PAS.0000000000000516","article-title":"Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma","volume":"39","author":"Kerr","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R13-20250613","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAP.0000000000000155","article-title":"Role of human papillomavirus in vulvar cancer","volume":"24","author":"Rakislova","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"R14-20250613","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41379-020-0527-y","article-title":"p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns","volume":"33","author":"Thompson","year":"2020","journal-title":"Mod Pathol"},{"key":"R15-20250613","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41379-021-00942-3","article-title":"Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma","volume":"35","author":"Salama","year":"2022","journal-title":"Mod Pathol"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.celrep.2014.05.012","article-title":"APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development","volume":"7","author":"Henderson","year":"2014","journal-title":"Cell Rep"},{"key":"R17-20250613","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/onc.2010.614","article-title":"p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors","volume":"30","author":"Romagosa","year":"2011","journal-title":"Oncogene"},{"key":"R18-20250613","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Consortium","year":"2017","journal-title":"Cancer Discov"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T15:03:04Z","timestamp":1749826984000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001077","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}